Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.
Ptashkin RN, Ewalt MD, Jayakumaran G, Kiecka I, Bowman AS, Yao J, Casanova J, Lin YD, Petrova-Drus K, Mohanty AS, Bacares R, Benhamida J, Rana S, Razumova A, Vanderbilt C, Balakrishnan Rema A, Rijo I, Son-Garcia J, de Bruijn I, Zhu M, Lachhander S, Wang W, Haque MS, Seshan VE, Wang J, Liu Y, Nafa K, Borsu L, Zhang Y, Aypar U, Suehnholz SP, Chakravarty D, Park JH, Abdel-Wahab O, Mato AR, Xiao W, Roshal M, Yabe M, Batlevi CL, Giralt S, Salles G, Rampal R, Tallman M, Stein EM, Younes A, Levine RL, Perales MA, van den Brink MRM, Dogan A, Ladanyi M, Berger MF, Brannon AR, Benayed R, Zehir A, Arcila ME. Ptashkin RN, et al. Among authors: benhamida j. Nat Commun. 2023 Oct 28;14(1):6895. doi: 10.1038/s41467-023-42585-9. Nat Commun. 2023. PMID: 37898613 Free PMC article.
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
Cocco E, Benhamida J, Middha S, Zehir A, Mullaney K, Shia J, Yaeger R, Zhang L, Wong D, Villafania L, Nafa K, Scaltriti M, Drilon A, Saltz L, Schram AM, Stadler ZK, Hyman DM, Benayed R, Ladanyi M, Hechtman JF. Cocco E, et al. Among authors: benhamida j. Cancer Res. 2019 Mar 15;79(6):1047-1053. doi: 10.1158/0008-5472.CAN-18-3126. Epub 2019 Jan 14. Cancer Res. 2019. PMID: 30643016 Free PMC article.
Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1.
Kinnaman MD, Hamill D, Yabe M, Powell J, Benhamida J, Hasselblatt M, Neumann M, Vokuhl C, Koelsche C, von Deimling A, Kolb EA, Solit DB, Ladanyi M, Dogan A, Shukla N. Kinnaman MD, et al. Among authors: benhamida j. JCO Precis Oncol. 2020 Oct 28;4:PO.20.00215. doi: 10.1200/PO.20.00215. eCollection 2020. JCO Precis Oncol. 2020. PMID: 33163846 Free PMC article. No abstract available.
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions.
Mata DA, Benhamida JK, Lin AL, Vanderbilt CM, Yang SR, Villafania LB, Ferguson DC, Jonsson P, Miller AM, Tabar V, Brennan CW, Moss NS, Sill M, Benayed R, Mellinghoff IK, Rosenblum MK, Arcila ME, Ladanyi M, Bale TA. Mata DA, et al. Acta Neuropathol Commun. 2020 Nov 9;8(1):186. doi: 10.1186/s40478-020-01058-6. Acta Neuropathol Commun. 2020. PMID: 33168106 Free PMC article.
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry.
Ho C, Syed M, Roshal M, Petrova-Drus K, Moung C, Yao J, Quesada AE, Benhamida J, Vanderbilt C, Liu Y, Zhu M, Yu W, Maciag L, Wang M, Ma Y, Gao Q, Rustad EH, Hultcrantz M, Diamond BT, Zheng-Lin B, Huang Y, Hutt K, Miller JE, Dogan A, Nafa K, Landgren O, Arcila ME. Ho C, et al. Among authors: benhamida j. J Mol Diagn. 2021 Feb;23(2):181-199. doi: 10.1016/j.jmoldx.2020.10.015. Epub 2020 Nov 17. J Mol Diagn. 2021. PMID: 33217553 Free PMC article.
Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY).
Bale TA, Sait SF, Benhamida J, Ptashkin R, Haque S, Villafania L, Sill M, Sadowska J, Akhtar RB, Liechty B, Juthani R, Ladanyi M, Fowkes M, Karajannis MA, Rosenblum MK. Bale TA, et al. Among authors: benhamida j. Acta Neuropathol. 2021 Jan;141(1):123-125. doi: 10.1007/s00401-020-02245-4. Epub 2020 Nov 23. Acta Neuropathol. 2021. PMID: 33226472 Free PMC article. No abstract available.
A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
Gupta S, Vanderbilt CM, Lin YT, Benhamida JK, Jungbluth AA, Rana S, Momeni-Boroujeni A, Chang JC, Mcfarlane T, Salazar P, Mullaney K, Middha S, Zehir A, Gopalan A, Bale TA, Ganly I, Arcila ME, Benayed R, Berger MF, Ladanyi M, Dogan S. Gupta S, et al. J Mol Diagn. 2021 Feb;23(2):253-263. doi: 10.1016/j.jmoldx.2020.11.003. Epub 2020 Dec 5. J Mol Diagn. 2021. PMID: 33285287 Free PMC article.
53 results